XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Income per Common Share Attributable to Magellan Health, Inc.
6 Months Ended
Jun. 30, 2018
Net Income per Common Share Attributable to Magellan Health, Inc.  
Net Income per Common Share Attributable to Magellan Health, Inc.

NOTE B—Net Income per Common Share Attributable to Magellan Health, Inc.

The following table reconciles income attributable to common shareholders (numerator) and shares (denominator) used in the computations of net income per share attributable to common shareholders (in thousands, except per share data) for the three and six months ended June 30:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2017

    

2018

    

2017

    

2018

    

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Magellan

 

$

5,500

 

$

13,551

 

$

23,247

 

$

25,003

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding—basic

 

 

23,108

 

 

24,569

 

 

23,060

 

 

24,460

 

Common stock equivalents—stock options

 

 

399

 

 

669

 

 

436

 

 

738

 

Common stock equivalents—RSAs

 

 

439

 

 

33

 

 

421

 

 

28

 

Common stock equivalents—RSUs

 

 

30

 

 

23

 

 

56

 

 

50

 

Common stock equivalents—PSUs

 

 

61

 

 

111

 

 

62

 

 

232

 

Common stock equivalents—employee stock purchase plan

 

 

 1

 

 

 2

 

 

 2

 

 

 2

 

Weighted average number of common shares outstanding—diluted

 

 

24,038

 

 

25,407

 

 

24,037

 

 

25,510

 

Net income attributable to Magellan per common share—basic

 

$

0.24

 

$

0.55

 

$

1.01

 

$

1.02

 

Net income attributable to Magellan per common share—diluted

 

$

0.23

 

$

0.53

 

$

0.97

 

$

0.98

 

The weighted average number of common shares outstanding for the three and six months ended June 30, 2017 and 2018 were calculated using outstanding shares of the Company’s common stock. Common stock equivalents included in the calculation of diluted weighted average common shares outstanding for the three and six months ended June 30, 2017 and 2018 represent stock options to purchase shares of the Company’s common stock, RSAs, RSUs, PSUs and stock purchased under the Employee Stock Purchase Plan.

The Company had additional potential dilutive securities outstanding representing 0.8 million and 0.7 million options for the three and six months ended June 30, 2017, respectively, and 0.5 million and 0.3 million for the three and six months ended June 30, 2018, respectively, that were not included in the computation of dilutive securities because they were anti-dilutive for the period. Had these shares not been anti-dilutive, all of these shares would not have been included in the net income attributable to common shareholder per common share calculation as the Company uses the treasury stock method of calculating diluted shares.